Retrospective Study
Copyright ©The Author(s) 2016.
World J Radiol. Mar 28, 2016; 8(3): 308-315
Published online Mar 28, 2016. doi: 10.4329/wjr.v8.i3.308
Figure 3
Figure 3 Volumetric analysis of patient 2 angiomyolipoma. A right renal AML underwent embolization prior a course of mTOR inhibitor therapy. Following this course, there was rebound growth involving the lipid, soft tissue, and vascular components of the tumor. Performance of a second embolization only temporarily curtailed tumoral growth. AML: Angiomyolipoma; mTOR: Mammalian target of rapamycin.